Michael Benkowitz
2020
In 2020, Michael Benkowitz earned a total compensation of $5.1M as President and Chief Operating Officer at United Therapeutics, a 74% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $3,160,903 |
|---|---|
| Non-Equity Incentive Plan | $1,003,298 |
| Salary | $944,423 |
| Other | $16,994 |
| Total | $5,125,618 |
Benkowitz received $3.2M of change in pension value and nonqualified deferred compensation earnings, accounting for 62% of the total pay in 2020.
Benkowitz also received $1M in non-equity incentive plan, $944.4K in salary and $17K in other compensation.
Rankings
In 2020, Michael Benkowitz's compensation ranked 2,154th out of 13,090 executives tracked by ExecPay. In other words, Benkowitz earned more than 83.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,154 out of 13,090 | 84th |
Division Manufacturing | 826 out of 5,617 | 85th |
Major group Chemicals And Allied Products | 295 out of 2,248 | 87th |
Industry group Drugs | 250 out of 1,948 | 87th |
Industry Pharmaceutical Preparations | 178 out of 1,453 | 88th |
Source: SEC filing on April 29, 2022.
Benkowitz's colleagues
We found three more compensation records of executives who worked with Michael Benkowitz at United Therapeutics in 2020.